Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01115 |
| Species: | Homo sapiens |
| Position : | chr3:181425707-181426096 |
| Year: | 2011 |
| Title: | Sox2 expression in breast tumours and activation in breast cancer stem cells |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | lung adenocarcinoma |
| PMID: | 21822303 |
| MONDO: | MONDO:0005032 |
| Tissue: | Lung |
| Tissue Ontology ID: | UBERON:0002048 |
| Cell Source: | A549 cell line |
| CVCL ID: | CVCL_0023 |
| Cell Type: | lung adenocarcinoma cell |
| Cell Ontology ID: | CL:0001069 |
| Experiment Type: | Enhancer activity assay |
| High Throughput Method: | |
| Low Throughput Method: | Luciferase Reporter Assay |
| Target gene : | SOX2 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01116 | chr3:181425707-181426096 | Breast | breast carcinoma cell | breast carcinoma |